Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Baojin Zhu, PhD
Director
Eli Lilly and Company
Poster(s):
(084) A Cohort Study to Evaluate the Real-World Utilization and Effectiveness of Bebtelovimab Compared to Nirmatrelvir/Ritonavir among Patients with Mild-to-Moderate COVID-19 Who Are at High Risk for Progressing to Severe Illness
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(086) Assessing the Robustness of Comparative Effectiveness Studies: An Applied Example Evaluating the Effectiveness of Bebtelovimab In COVID-19
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
